{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:20:57Z","timestamp":1768483257143,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00210-025-03906-5","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:47:44Z","timestamp":1740030464000},"page":"10353-10366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prolonged administration of letrozole induces polycystic ovary syndrome leading to osteoporosis in rats: model development and validation studies"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4596-8288","authenticated-orcid":false,"given":"Zakiya","family":"Usmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheeraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeba","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taru","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9299-414X","authenticated-orcid":false,"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayeena","family":"Altaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-5712","authenticated-orcid":false,"given":"Showkat Rasool","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"3906_CR1","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1210\/EN.2012-1105","volume":"153","author":"D Abramovich","year":"2012","unstructured":"Abramovich D, Irusta G, Bas D et al (2012) Angiopoietins\/TIE2 System and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Endocrinology 153:3446\u20133456. https:\/\/doi.org\/10.1210\/EN.2012-1105","journal-title":"Endocrinology"},{"key":"3906_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/J.ABB.2019.06.009","volume":"671","author":"MM Atef","year":"2019","unstructured":"Atef MM, Abd-Ellatif RN, Emam MN et al (2019) Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: targeting mitochondrial approach (selenium in PCOS). Arch Biochem Biophys 671:245\u2013254. https:\/\/doi.org\/10.1016\/J.ABB.2019.06.009","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"3906_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.arcmed.2006.04.006","volume":"37","author":"C Baravalle","year":"2006","unstructured":"Baravalle C, Salvetti NR, Mira GA et al (2006) Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res 37(7):830\u2013839. https:\/\/doi.org\/10.1016\/j.arcmed.2006.04.006","journal-title":"Arch Med Res"},{"issue":"6","key":"3906_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00198-023-07013-0","volume":"35","author":"Y Cai","year":"2024","unstructured":"Cai Y, Jun G, Zhuang X (2024) Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study. Osteoporos Int 35(6):1089\u20131098. https:\/\/doi.org\/10.1007\/s00198-023-07013-0","journal-title":"Osteoporos Int"},{"issue":"8","key":"3906_CR5","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"ASL Caldwell","year":"2014","unstructured":"Caldwell ASL, Middleton LJ, Jimenez M et al (2014) Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155(8):3146\u201359. https:\/\/doi.org\/10.1210\/en.2014-1196","journal-title":"Endocrinology"},{"issue":"3","key":"3906_CR6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/ijms23031376","volume":"23","author":"CH Cheng","year":"2022","unstructured":"Cheng CH, Chen LR, Chen KH (2022) Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci 23(3):1376. https:\/\/doi.org\/10.3390\/ijms23031376","journal-title":"Int J Mol Sci"},{"key":"3906_CR7","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/S43032-024-01545-4\/METRICS","volume":"31","author":"RCSR Danduga","year":"2024","unstructured":"Danduga RCSR, Kurapati AS, Shaik RA et al (2024) Synergistic amelioration of letrozole-induced polycystic ovary syndrome in rats: a therapeutic approach with apple cider vinegar and metformin combination. Reprod Sci 31:2861\u20132876. https:\/\/doi.org\/10.1007\/S43032-024-01545-4\/METRICS","journal-title":"Reprod Sci"},{"issue":"25","key":"3906_CR8","doi-asserted-by":"publisher","first-page":"e29434","DOI":"10.1097\/MD.0000000000029434","volume":"101","author":"CX Dang","year":"2022","unstructured":"Dang CX, Wang D, Yu X et al (2022) Exploring the relationship between osteoporosis and polycystic ovary syndrome based on bioinformatics. Med (United States) 101(25):e29434. https:\/\/doi.org\/10.1097\/MD.0000000000029434","journal-title":"Med (United States)"},{"key":"3906_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F et al (2021) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne) 12:1\u201314. https:\/\/doi.org\/10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7\u20138","key":"3906_CR10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1345\/aph.1M096","volume":"43","author":"KR Eckmann","year":"2009","unstructured":"Eckmann KR, Kockler DR (2009) Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome. Ann Pharmacother 43(7\u20138):1338\u20131346. https:\/\/doi.org\/10.1345\/aph.1M096","journal-title":"Ann Pharmacother"},{"key":"3906_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/HUMREP\/DEH098","volume":"19","author":"BCJM Fauser","year":"2004","unstructured":"Fauser BCJM, Tarlatzis F et al (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347. https:\/\/doi.org\/10.1093\/HUMREP\/DEH098","journal-title":"Hum Reprod"},{"key":"3906_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/J.ARCMED.2003.10.005","volume":"35","author":"H Kafali","year":"2004","unstructured":"Kafali H, Iriadam M, Ozardali I, Demir N (2004) Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res 35:103\u2013108. https:\/\/doi.org\/10.1016\/J.ARCMED.2003.10.005","journal-title":"Arch Med Res"},{"key":"3906_CR13","doi-asserted-by":"publisher","unstructured":"Khaled N, El-Bahy ASA, Radwan R et al (2019) Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: comparison with metformin. Life Sci 232:116640. https:\/\/doi.org\/10.1016\/J.LFS.2019.116640","DOI":"10.1016\/J.LFS.2019.116640"},{"key":"3906_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FENDO.2018.00735\/BIBTEX","volume":"9","author":"EJ Kim","year":"2018","unstructured":"Kim EJ, Jang M, Choi JH et al (2018) An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (Pcos): post-pubertal improve pcos\u2019s features. Front Endocrinol (Lausanne) 9:1\u20137. https:\/\/doi.org\/10.3389\/FENDO.2018.00735\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3906_CR15","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/JOE-16-0405","volume":"232","author":"A Krishnan","year":"2017","unstructured":"Krishnan A, Muthusami S (2017) Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol 232(2):R99\u2013R113. https:\/\/doi.org\/10.1530\/JOE-16-0405","journal-title":"J Endocrinol"},{"key":"3906_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/medicina56030100","volume":"56","author":"A Krishnan","year":"2020","unstructured":"Krishnan A, Muthusami S, Periyasamy L et al (2020) Effect of DHT-induced hyperandrogenism on the pro-inflammatory cytokines in a rat model of polycystic ovary morphology. Medicina 56:100. https:\/\/doi.org\/10.3390\/medicina56030100","journal-title":"Medicina"},{"key":"3906_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0000000000000563","volume":"64","author":"JA Lentscher","year":"2021","unstructured":"Lentscher JA, Decherney AH (2021) Clinical presentation and diagnosis of polycystic ovarian syndrome. Clin Obstet Gynecol 64:3\u201311. https:\/\/doi.org\/10.1097\/GRF.0000000000000563","journal-title":"Clin Obstet Gynecol"},{"issue":"8","key":"3906_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","volume":"30","author":"ME Lujan","year":"2008","unstructured":"Lujan ME, Chizen DR, Pierson RA (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Canada 30(8):671\u2013679. https:\/\/doi.org\/10.1016\/S1701-2163(16)32915-2","journal-title":"J Obstet Gynaecol Canada"},{"issue":"4","key":"3906_CR19","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/ijms22041667","volume":"22","author":"A Mancini","year":"2021","unstructured":"Mancini A, Bruno C, Vergani E et al (2021) Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci 22(4):1667. https:\/\/doi.org\/10.3390\/ijms22041667","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3906_CR20","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1210\/en.2007-0168","volume":"148","author":"L Manner\u00e5s","year":"2007","unstructured":"Manner\u00e5s L, Cajander S, Holm\u00e4ng A et al (2007) A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148(8):3781\u20133791. https:\/\/doi.org\/10.1210\/en.2007-0168","journal-title":"Endocrinology"},{"issue":"4A","key":"3906_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1590\/S1519-69842002000400008","volume":"62","author":"FK Marcondes","year":"2002","unstructured":"Marcondes FK, Bianchi FJ, Tanno AP (2002) Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian J Biol 62(4A):609\u201314. https:\/\/doi.org\/10.1590\/S1519-69842002000400008","journal-title":"Brazilian J Biol"},{"key":"3906_CR22","doi-asserted-by":"publisher","first-page":"1163771","DOI":"10.3389\/FENDO.2023.1163771\/BIBTEX","volume":"14","author":"EG Mills","year":"2023","unstructured":"Mills EG, Abbara A, Dhillo WS, Comninos AN (2023) Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health. Front Endocrinol (Lausanne) 14:1163771. https:\/\/doi.org\/10.3389\/FENDO.2023.1163771\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"3906_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jocd.2022.02.005","volume":"25","author":"M Noroozzadeh","year":"2022","unstructured":"Noroozzadeh M, Amiri M, Farhadi-Azar M, Ramezani Tehrani F (2022) Bone health in women with polycystic ovary syndrome: a narrative review. J Clin Densitom 25(4):606\u2013614. https:\/\/doi.org\/10.1016\/j.jocd.2022.02.005","journal-title":"J Clin Densitom"},{"key":"3906_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmb2.12262","volume":"18","author":"S Osuka","year":"2019","unstructured":"Osuka S, Nakanishi N, Murase T et al (2019) Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol 18:151\u2013160. https:\/\/doi.org\/10.1002\/rmb2.12262","journal-title":"Reprod Med Biol"},{"key":"3906_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/01.ATV.20.7.1817\/ASSET\/423F53B4-770E-4B10-8AED-3EA96446BBE6\/ASSETS\/GRAPHIC\/HQ0701375005.JPEG","volume":"20","author":"P Parini","year":"2000","unstructured":"Parini P, Angelin B, Stavr\u00e9us-Evers A et al (2000) Biphasic effects of the natural estrogen 17\u03b2-estradiol on hepatic cholesterol metabolism in intact female rats. Arterioscler Thromb Vasc Biol 20:1817\u20131823. https:\/\/doi.org\/10.1161\/01.ATV.20.7.1817\/ASSET\/423F53B4-770E-4B10-8AED-3EA96446BBE6\/ASSETS\/GRAPHIC\/HQ0701375005.JPEG","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3906_CR26","doi-asserted-by":"publisher","first-page":"00937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:00937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","journal-title":"Mol Metab"},{"key":"3906_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00580-023-03446-5","volume":"32","author":"MZ Shah","year":"2023","unstructured":"Shah MZ, Shrivastava VK (2023) Ameliorative effects of quercetin on endocrine and metabolic abnormalities associated with experimentally induced polycystic ovary syndrome in mice. Comparative Clin Patho 32:383\u2013391. https:\/\/doi.org\/10.1007\/s00580-023-03446-5","journal-title":"Comparative Clin Patho"},{"key":"3906_CR28","doi-asserted-by":"publisher","first-page":"110468","DOI":"10.1016\/j.cbi.2023.110468","volume":"377","author":"MZ Shah","year":"2023","unstructured":"Shah MZ, Shrivastava VK, Mir MA, Olaniyi KS (2023) Role of diacerein on steroidogenesis and folliculogenesis related genes in ovary of letrozole-induced PCOS mice. Chemico-Biolog Interact 377:110468. https:\/\/doi.org\/10.1016\/j.cbi.2023.110468","journal-title":"Chemico-Biolog Interact"},{"key":"3906_CR29","doi-asserted-by":"publisher","first-page":"122280","DOI":"10.1016\/j.lfs.2023.122280","volume":"335","author":"G Sudhakaran","year":"2023","unstructured":"Sudhakaran G, Priya PS, Jagan K et al (2023) Osteoporosis in polycystic ovary syndrome (PCOS) and involved mechanisms. Life Sci 335:122280. https:\/\/doi.org\/10.1016\/j.lfs.2023.122280","journal-title":"Life Sci"},{"issue":"8","key":"3906_CR30","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS (2019) Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 3(8):1545\u20131573. https:\/\/doi.org\/10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"3906_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111141","volume":"125","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Wang H, Ding H et al (2023) Hyperandrogenism drives ovarian inflammation and pyroptosis: a possible pathogenesis of PCOS follicular dysplasia. Int Immunopharmacol 125:111141. https:\/\/doi.org\/10.1016\/j.intimp.2023.111141","journal-title":"Int Immunopharmacol"},{"key":"3906_CR32","doi-asserted-by":"publisher","unstructured":"Xu J, Dun J, Yang J et al (2020) Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal pathways. Med Sci Monit 26:e923073. https:\/\/doi.org\/10.12659\/MSM.923073","DOI":"10.12659\/MSM.923073"},{"key":"3906_CR33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s43032-020-00310-7","volume":"28","author":"HE Young","year":"2021","unstructured":"Young HE, Ward WE (2021) The relationship between polycystic ovarian syndrome, periodontal disease, and osteoporosis. Reprod Sci 28:950\u2013962. https:\/\/doi.org\/10.1007\/s43032-020-00310-7","journal-title":"Reprod Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03906-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03906-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03906-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T09:58:25Z","timestamp":1755079105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03906-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3906"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03906-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Animal Ethics Committee (IAEC), Jamia Hamdard, New Delhi, India (Registration No. 173\/GO\/RE\/S\/2000\/CCSEA) under the proposal number 1976.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}